Pharma Companies Need Better Incentives, Innovation To Invest In Neglected Diseases
EurActiv.com: Pharma firms pressed to tackle neglected diseases in developing world
“Poverty-related and neglected diseases (PRNDs) disproportionately affect the world’s poorest populations. Better incentives are needed for pharmaceutical companies to develop drugs, health campaigners say. Europe plays a critical role in developing new PRND products that are saving millions of lives and millions of euros in the world’s poorest countries…” (Jacobsen, 3/11).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.